Back to Top
Go Back
Journal Photo for Nature Medicine
Peer reviewed only Open Access

Nature Medicine (NM)

Publisher : Springer Nature
Molecular Biology Biochemistry Genetics
Claim Your Journal Get PRC Visit Website
e-ISSN 1546-170X
p-ISSN 1078-8956
Issue Frequency Monthly
Est. Year 1995
Mobile 2127269325
DOI YES
Country United States
Language English
APC YES
Impact Factor Assignee Google Scholar
Email medicine@us.nature.com

Journal Descriptions

The criteria for consideration of translational and clinical research in Nature Medicine are originality, timeliness and impact on improving human health by addressing unmet clinical needs. Original research ranges from new concepts in human biology and disease pathogenesis to new therapeutic modalities and drug development, to all phases of clinical work, as well as innovative technologies aimed at improving human health. Nature Medicine is a monthly journal publishing original peer-reviewed research in all areas of medicine on the basis of its originality, timeliness, interdisciplinary interest and impact on improving human health. Nature Medicine also publishes commissioned content, including News, Reviews and Perspectives, aimed at contextualizing the latest advances in translational and clinical research to reach a wide audience of M.D. and Ph.D. readers. All editorial decisions are made by a team of full-time professional editors.

Nature Medicine (NM) is :-

  • International, Peer-Reviewed, Open Access, Refereed, Molecular Biology, Biochemistry, Genetics, CELL BIOLOGY , Online or Print , Monthly Journal

  • UGC Approved, ISSN Approved: P-ISSN P-ISSN: 1078-8956, E-ISSN: 1546-170X, Established: 1995,
  • Provides Crossref DOI

  • Indexed in: Scopus

  • Not indexed in WoS, DOAJ, PubMed, UGC CARE

Indexing

Publications of NM

Posthospitalization COVID-19 cognitive deficits at 1 year are global and associated with elevated brain injury markers and gray matter volume reduct...
Edward T. Bullmore September, 2024
The spectrum, pathophysiology and recovery trajectory of persistent post-COVID-19 cognitive deficits are unknown, limiting our ability to develop prevention and treatment strategies. We repo...
Cancer genes and the pathways they control
Bert Vogelstein July, 2004
The revolution in cancer research can be summed up in a single sentence: cancer is, in essence, a genetic disease. In the last decade, many important genes responsible for the genesis of var...
Circulating mutant DNA to assess tumor dynamics
Bert Vogelstein July, 2008
The measurement of circulating nucleic acids has transformed the management of chronic viral infections such as HIV. The development of analogous markers for individuals with cancer could si...
Analysis of mismatch repair genes in hereditary non–polyposis colorectal cancer patients
Bert Vogelstein February, 1996
Hereditary non–polyposis colorectal cancer (HNPCC) is an autosomal dominant disorder characterized by the early onset of colorectal cancer and linked to germline defects in at least four m...
Combinatorial chemoprevention of intestinal neoplasia
Bert Vogelstein September, 2000
A combination of two drugs afforded remarkable protection from intestinal neoplasia in APCMin/+ mice, a murine model of human familial adenomatous polyposis (FAP). One of the drugs was sulin...
Contribution of bone marrow–derived endothelial cells to human tumor vasculature
Bert Vogelstein February, 2005
It has been shown that bone marrow–derived stem cells can form a major fraction of the tumor endothelium in mouse tumors. To determine the role of such cells in human tumor angiogenesis, w...